Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 7

1.

68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.

Brom M, Oyen WJ, Joosten L, Gotthardt M, Boerman OC.

Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1345-55. doi: 10.1007/s00259-009-1363-y. Epub 2010 Jan 29.

2.

[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.

Wild D, Béhé M, Wicki A, Storch D, Waser B, Gotthardt M, Keil B, Christofori G, Reubi JC, Mäcke HR.

J Nucl Med. 2006 Dec;47(12):2025-33.

3.

A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents.

Gotthardt M, Lalyko G, van Eerd-Vismale J, Keil B, Schurrat T, Hower M, Laverman P, Behr TM, Boerman OC, Göke B, Béhé M.

Regul Pept. 2006 Dec 10;137(3):162-7. Epub 2006 Aug 22.

PMID:
16930741
4.

Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.

Theodorakis MJ, Carlson O, Michopoulos S, Doyle ME, Juhaszova M, Petraki K, Egan JM.

Am J Physiol Endocrinol Metab. 2006 Mar;290(3):E550-9. Epub 2005 Oct 11.

5.

Glucagon-like peptide 1(GLP-1) in biology and pathology.

Meier JJ, Nauck MA.

Diabetes Metab Res Rev. 2005 Mar-Apr;21(2):91-117. Review.

PMID:
15759282
6.

Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting.

Reubi JC, Waser B.

Eur J Nucl Med Mol Imaging. 2003 May;30(5):781-93. Epub 2003 Apr 18. Review.

PMID:
12707737
7.

Glucagon-like peptide-1.

Doyle ME, Egan JM.

Recent Prog Horm Res. 2001;56:377-99. Review.

PMID:
11237222

Supplemental Content

Support Center